NCT06236022View on ClinicalTrials.gov

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

PHASE4RecruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Dilated CardiomyopathyKaposi's Sarcoma-Associated Herpesvirus Infection
Interventions
DRUG

Sirolimus

at a dose of 2 mg once daily

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Wuhan Central Hospital

OTHER

collaborator

Wuhan Fourth Hospital

UNKNOWN

collaborator

Wuhan University

OTHER

lead

Tongji Hospital

OTHER